Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.
OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.
AnaCardio is a clinical stage biopharmaceutical company developing novel drugs to treat heart failure.
Breye Therapeutics, a biopharmaceutical firm that provide cutting-edge oral treatments for the management of retinal vascular diseases.
Based on our deep science and focused on patients in need.
Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.
Tempus provides technology, genomic testing, data, and AI solutions for healthcare, research, and life sciences applications.
MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
Claris Biotherapeutics develops biologic therapies for corneal diseases and other disorders affecting the ocular surface.
Crystalys Therapeutics is a clinical-stage biopharmaceutical company that develops targeted therapies for gout and hyperuricemia.
Roslin Technologies is a biotechnology company that focuses on developing technologies for the agricultural and animal health sectors.
The Protein Brewery specializes in developing and making animal-free-based protein in a sustainable way.
cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities of therapeutic solutions.
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
Windward Bio develops monoclonal antibodies for advanced immunological diseases.
CoultreonBiopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.
Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.
Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.
Adcendo is a biotech company that develops antibody-drug conjugates (ADCs) to target cancers with high unmet medical needs.
SUBRA A/S focuses on innovation, industrial-scale production, and creating a sustainable impact.
Route 92 Medical is a medical device company developing a catheter to treat stroke.
Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.
Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.
Novo Holdings has invested in 216 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Novo Holdings's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Biopharma. The firm invests across 20 different industry categories.
Among tracked funding rounds, Mirum Pharmaceuticals received $600.0M in a Post-IPO Debt round. Novo Holdings's total known invested capital is $18.6B.
Novo Holdings's average investment size is $86.1M across its portfolio of 216 companies.
Recent Novo Holdings portfolio additions include Disc Medicine, OMass Therapeutics, AnaCardio, Breye Therapeutics, AvenCell. These companies were founded in 2020 or later.